<DOC>
	<DOCNO>NCT01603888</DOCNO>
	<brief_summary>B-type natriuretic Peptide ( BNP ) cardiac hormone secrete cardiac myocytes response volume load . Plasma level BNP , measure immunoassay method , elevate patient heart diseases . However , biological effect BNP blunt heart failure cardiac condition . Moreover , peptide level also elevate non cardiac condition neonatal period , sepsis renal failure . Recent investigation suggest alteration peptide molecular structure heart failure . These alteration may explain , least partially , reduce biological activity BNP heart failure . Immunoreactive BNP NT-proBNP identify human urine . It suggest urinary BNP correlate plasma BNP , may serve non-invasive measure cardiac marker . It unclear BNP fraction clear urine health disease . The aim propose study elucidate precisely molecular form BNP various disease specific physiological state plasma urine infant child .</brief_summary>
	<brief_title>Molecular Forms Plasma Urinary B-type Natriuretic Peptide Its N-terminal Prohormone Health Disease Pediatric Cardiology</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<criteria>1 . Healthy newborn infant normal pregnancy delivery 2 . Premature infants 3 . Infants child heart disease NTproBNP level take part cardiac evaluation 1 . Patients non cardiac disease ( renal , hepatic ) 2 . Patients acute urinary disease acute noncardiac disease .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>child heart disease</keyword>
	<keyword>infant</keyword>
	<keyword>healthy newborn</keyword>
</DOC>